BlackRock »

Immix Biopharma shares owned by BlackRock

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $21k 14k 1.49

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Immix Biopharma

AIGH Capital Management
Bleichroeder
Cable Car Capital
Vanguard Group
Geode Capital Management
Royal Bank of Canada
Morgan Stanley
Tocqueville Asset Management
State Street Corporation
Northern Trust
Private Advisor
Invst
Commonwealth Equity Services
Tritonpoint Wealth
Squarepoint Ops

View all funds holding Immix Biopharma